{"schema_version":"1.0","hypothesis_id":40760,"triple":{"drug":"liraglutide","drug_canonical":"liraglutide","mediator":"GLP-1R","mediator_canonical":"glp-1r","outcome":"pancreatic ductal adenocarcinoma","outcome_canonical":"pancreatic ductal adenocarcinoma"},"domain":{"domain":"cross_domain","source":"type_2_diabetes","target":"pancreatic_cancer"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.1038/s41598-024-64774-2","pmid":"38877189","year":2024,"roles":["drug_mediator"],"title":"Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo","journal":"Sci Rep","work_id":240823,"publication_date":"2024-06-14"},{"doi":"10.1016/j.bcp.2024.116170","pmid":"38548245","year":2024,"roles":["drug_mediator"],"title":"Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE -/- mice","journal":"Biochem Pharmacol","work_id":240807,"publication_date":"2024-03-26"},{"doi":"10.14715/cmb/2023.69.14.37","pmid":"38279433","year":2023,"roles":["drug_mediator"],"title":"GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells","journal":"Cell Mol Biol (Noisy-le-grand)","work_id":240596,"publication_date":"2023-12-20"},{"doi":"10.1016/j.biopha.2020.110523","pmid":"32702632","year":2020,"roles":["drug_mediator"],"title":"Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R","journal":"Biomed Pharmacother","work_id":237086,"publication_date":"2020-07-20"},{"doi":"10.1126/scitranslmed.aay8071","pmid":"32132220","year":2020,"roles":["drug_mediator"],"title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","journal":"Sci Transl Med","work_id":233603,"publication_date":"2020-03-04"},{"doi":"10.1152/ajpheart.00486.2019","pmid":"31729903","year":2019,"roles":["drug_mediator"],"title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension","journal":"Am J Physiol Heart Circ Physiol","work_id":239518,"publication_date":"2019-11-15"},{"doi":"10.1186/s12950-019-0218-y","pmid":"31182934","year":2019,"roles":["drug_mediator"],"title":"The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis","journal":"J Inflamm (Lond)","work_id":235751,"publication_date":"2019-06-06"},{"doi":"10.1161/atv.0000615456.97862.30","pmid":"31747801","year":2019,"roles":["drug_mediator"],"title":"Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension","journal":"Arterioscler Thromb Vasc Biol","work_id":232476,"publication_date":"2019-11-21"},{"doi":"10.1089/dna.2018.4397","pmid":"30403540","year":2018,"roles":["drug_mediator"],"title":"Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways","journal":"DNA Cell Biol","work_id":248858,"publication_date":"2018-11-07"},{"doi":"10.2147/copd.s175145","pmid":"30349227","year":2018,"roles":["drug_mediator"],"title":"Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients","journal":"Int J Chron Obstruct Pulmon Dis","work_id":245107,"publication_date":"2018-10-01"},{"doi":"10.1038/s41419-017-0217-y","pmid":"29434185","year":2018,"roles":["drug_mediator"],"title":"Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat","journal":"Cell Death Dis","work_id":233876,"publication_date":"2018-02-12"},{"doi":"10.1097/mpa.0000000000000521","pmid":"26495786","year":2015,"roles":["mediator_outcome"],"title":"Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues","journal":"Pancreas","work_id":173366,"publication_date":"2015-10-24"}],"source_paper_count":12,"extracted_claims":[{"side":"drug_mediator","object":"GLP-1R","context":"in endothelial cells of mice with arterial hypertension","subject":"liraglutide","work_id":232476,"claim_id":165375,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in NTS of rats","subject":"liraglutide","work_id":233603,"claim_id":168365,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in chondrocytes","subject":"liraglutide","work_id":233876,"claim_id":169072,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in a rat model of knee osteoarthritis","subject":"liraglutide","work_id":235751,"claim_id":173768,"polarity":"positive","predicate":"upregulates","confidence":0.8,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"general (GLP-1 receptor agonist)","subject":"liraglutide","work_id":237086,"claim_id":176977,"polarity":"positive","predicate":"activates","confidence":0.95,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in a rat model of placental ischemia","subject":"liraglutide","work_id":239518,"claim_id":182455,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in TT/GLP-1R and TCP-1/GLP-1R cell lines","subject":"liraglutide","work_id":240596,"claim_id":184828,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in APOE -/- mice","subject":"liraglutide","work_id":240807,"claim_id":185178,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in CCA cells (in vitro and in vivo)","subject":"liraglutide","work_id":240823,"claim_id":185218,"polarity":"positive","predicate":"downregulates","confidence":0.85,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in PBMCs of COPD patients","subject":"liraglutide","work_id":245107,"claim_id":195128,"polarity":"positive","predicate":"upregulates","confidence":0.9,"extraction_run_id":27},{"side":"drug_mediator","object":"GLP-1R","context":"in MC3T3-E1 cells","subject":"Liraglutide","work_id":248858,"claim_id":203267,"polarity":"positive","predicate":"upregulates","confidence":0.95,"extraction_run_id":27},{"side":"mediator_outcome","object":"pancreatic ductal adenocarcinoma","context":"during progression from normal cells to PDAC","subject":"GLP-1R","work_id":173366,"claim_id":125886,"polarity":"negative","predicate":"correlates_with","confidence":0.95,"extraction_run_id":23}],"extracted_claim_count":12,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[23,27]},"bridge":{"a_to_b_predicate":"upregulates","b_to_c_predicate":"correlates_with","a_to_b_evidence_count":11,"b_to_c_evidence_count":1,"edge_support_log_ab":2.4849066497880004,"edge_support_log_bc":0.6931471805599453,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.31780538303479455,"score":0.31780538303479455,"quality_tier":"high","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:41.695630+00:00"}